MedPath

Feasibility study of outpatient chemotherapy with Capecitabine plus fractional Cisplatin for Advanced or Recurrent Gastric Cancer

Phase 1
Recruiting
Conditions
Patients with unresctable or recurrent gastric cancer
Registration Number
JPRN-UMIN000006385
Lead Sponsor
ihon Medical School Musasikosugi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1.Pregnant or breast-feeding women were excluded 2.Clinically significant cardiovascular disease 3.Evidence of central nervous system metastases 4.Major surgery or trauma in previous 4 weeks. 5.Inappropriate for this study judged by the attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety [Incidence of dose limiting toxicity] Determine recommend dose
Secondary Outcome Measures
NameTimeMethod
Progression free survival
© Copyright 2025. All Rights Reserved by MedPath